The
oncology drugs are used for the treatment of cancer. The oncology drug market
is a segment in the pharmaceutical drug market. The rise in new cancer cases,
which is 14.1million in 2012, is the major driving factor for the drugs market.
The other factors driving the market are the demand for increase in treatment
by aging population, and improvements in results of treatment.
As
the price varies from $5,000-$92,000 per month, the rising cost is the major
restraint of the oncology market There are many new brands of drug available in
the market that has good success rates, but the challenge faced is the
accessibility of the drugs due to high cost. The cost correction of these
branded drugs can provide a good opportunity for efficient and effective
treatment.
The
key players profiled in this report are: Bayer healthcare pharmaceuticals,
Celgene, Eli Lilly & Co, ImClone Systems Inc., GlaxoSmithKline, Merck &
Co, Novartis Pharmaceuticals, Pfizer Inc., Roche and Sanofi.
KEY BENEFITS:
• The report provides in-depth analysis about types of drugs, treatment , types of cancer and geography in the oncology drugs market
• The report provides in-depth analysis about types of drugs, treatment , types of cancer and geography in the oncology drugs market
• The report evaluates the key factors that prove to be drivers and restraints for the market
• The report discuses the oncology drugs market based on the various segments to forecast growth till 2020.
• The report discuses the market factors in various geographic regions and also explores business opportunities
• The report analyzes the strategies applied by the profiled key players in the market
KEY MARKET SEGMENT:
GLOBAL MARKET BY, TYPE
OF CANCER
• Blood Cancer
• Bone Cancer
• Brain Cancer
• Breast Cancer
• Digestive/ Gastrointestinal Cancer
• Endocrine Cancers
• Eye Cancer
• Genitourinary Cancers
• Gynecologic Cancers
• Head & Neck Cancers
• Respiratory/Lung Cancers
• Skin Cancers
• Blood Cancer
• Bone Cancer
• Brain Cancer
• Breast Cancer
• Digestive/ Gastrointestinal Cancer
• Endocrine Cancers
• Eye Cancer
• Genitourinary Cancers
• Gynecologic Cancers
• Head & Neck Cancers
• Respiratory/Lung Cancers
• Skin Cancers
GLOBAL MARKET BY, TYPE
OF CANCER TREATMENTS
• Surgery
• Chemotherapy
• Radiation Therapy
• Targeted Therapy
• Immunotherapy (Biologic Therapy)
• Hormonal Therapy
• Hyperthermia
• Stem Cell Transplant
• Others
• Surgery
• Chemotherapy
• Radiation Therapy
• Targeted Therapy
• Immunotherapy (Biologic Therapy)
• Hormonal Therapy
• Hyperthermia
• Stem Cell Transplant
• Others
GLOBAL MARKET BY, TYPE
OF CANCER DRUGS
• Rituxan
• Herceptin
• Avastin
• Gleevec
• Velcade
• Sutent
• Sprycel
• Nexavar
• Tasigna
• Afinitor / Votubia
• Xgeva
• Yervoy
• Erbitux
• Rituxan
• Herceptin
• Avastin
• Gleevec
• Velcade
• Sutent
• Sprycel
• Nexavar
• Tasigna
• Afinitor / Votubia
• Xgeva
• Yervoy
• Erbitux
KEY AUDIENCE
• Drug manufacturers
• Hospital
• Private and government research institutes
• Academic institutes
• Drug manufacturers
• Hospital
• Private and government research institutes
• Academic institutes
About
Us:
With
the arsenal of different search reports, we help you here to look and buy
research reports that will be helpful to you and your organization. Our
research reports have the capability and authenticity to support your
organization for growth and consistency.
With
the window of opportunity getting open and shut at a speed of light, it has
become very important to survive in the market and only the fittest and
competent enough can do so. So, we try and provide with latest changes in the
market that can suit your needs and help you take decision accordingly.
Contact
Us:
Sona Padman
5320 SW Macadam Avenue,
Suite 100,
Portland, OR 97239,
United States.
Direct: +1 (617) 674-4143
Toll Free: +1 (855) 711-1555
Fax: +1 (855) 550-5975
Email:sales@bigmarketresearch.com
No comments:
Post a Comment